Skip to content

A User Study of the Soniflow System for Nasal Congestion Relief

A User Study of the Soniflow System for Nasal Congestion Relief

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04910139
Enrollment
50
Registered
2021-06-02
Start date
2020-07-15
Completion date
2021-01-26
Last updated
2023-10-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nasal Congestion

Brief summary

The Soniflow System consists of an acoustic vibrational headband paired with a Smartphone App to provide rapid relief of nasal congestion.

Detailed description

The Soniflow System is a non-invasive device to provide rapid relief of nasal congestion. It consists of a headband with ultrasound transducers (hardware) coupled to a Smartphone application (software).

Interventions

DEVICESoniflow System

Treatment using acoustic vibrational headband worn circumferentially at the level of the forehead paired with a Smartphone App.

Sponsors

Third Wave Therapeutics
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. Subject is \>18 years of age 2. Subject has had moderate to severe symptoms of nasal congestion for \>3 months (TNSS rating of 2 or 3) 3. Subject has signed IRB-approved informed consent form

Exclusion criteria

1. Subject has neurologic comorbidities 2. Subject has active dental infection 3. Subject is pregnant 4. Subject has implanted intracranial electrostimulation device(s) (e.g. cochlear implant, deep brain stimulator) 5. Subject has undergone sinonasal or craniomaxillofacial surgery within the lats 3 months 6. Subject has been diagnosed with intracranial hemorrhage within the last 6 months 7. Subject has open scalp wounds or rashes 8. Subject has any history of craniotomy without replacement of a bone flap 9. Subject has elevated sensitivity to sound 10. Any physical condition that in the investigator's opinion would prevent adequate study participation or pose increased risk

Design outcomes

Primary

MeasureTime frameDescription
Total Nasal Symptom Score20 minutesTNSS is a measure of nasal congestion, measured as the sum of four symptom scores for rhinorrhea, nasal congestion, nasal itching, and sneezing (using a scale of 0=None, 1=Mild, 2=Moderate, or 3=Severe). The minimum TNSS value is 0. The maximum TNSS value is 12. Lower TNSS score means a better outcome

Secondary

MeasureTime frameDescription
Visual Analog Scale (VAS) for Headache20 minutesVisual Analog Scale (VAS) for Headache, using a scale of 0-10. 0 is the minimum and 10 is maximum on this scale. Lower scores mean a better outcome.
Visual Analog Scale (VAS) for Facial Pain20 minutesVisual Analog Scale (VAS) for Facial Pain, using a scale of 0-10. 0 is minimum and 10 is the maximum value for this scale. Lower scores mean a better outcome.

Countries

United States

Participant flow

Participants by arm

ArmCount
Treatment
Treatment using acoustic energy Soniflow System: Treatment using acoustic vibrational headband worn circumferentially at the level of the forehead paired with a Smartphone App.
50
Total50

Baseline characteristics

CharacteristicTreatment
Age, Categorical
Age
<=18 years
0 Participants
Age, Categorical
Age
>=65 years
4 Participants
Age, Categorical
Age
Between 18 and 65 years
46 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
3 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
46 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
1 Participants
Region of Enrollment
United States
50 participants
Sex: Female, Male
Female
20 Participants
Sex: Female, Male
Male
30 Participants
Total Nasal Symptom Score4.1 units on a scale

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 50
other
Total, other adverse events
0 / 50
serious
Total, serious adverse events
0 / 50

Outcome results

Primary

Total Nasal Symptom Score

TNSS is a measure of nasal congestion, measured as the sum of four symptom scores for rhinorrhea, nasal congestion, nasal itching, and sneezing (using a scale of 0=None, 1=Mild, 2=Moderate, or 3=Severe). The minimum TNSS value is 0. The maximum TNSS value is 12. Lower TNSS score means a better outcome

Time frame: 20 minutes

Population: Adult subjects with nasal congestion

ArmMeasureValue (MEAN)
TreatmentTotal Nasal Symptom Score2.0 score on a scale
Secondary

Visual Analog Scale (VAS) for Facial Pain

Visual Analog Scale (VAS) for Facial Pain, using a scale of 0-10. 0 is minimum and 10 is the maximum value for this scale. Lower scores mean a better outcome.

Time frame: 20 minutes

Population: adults with nasal congestion

ArmMeasureValue (MEAN)
TreatmentVisual Analog Scale (VAS) for Facial Pain0.9 score on a scale (of 0-10)
Secondary

Visual Analog Scale (VAS) for Headache

Visual Analog Scale (VAS) for Headache, using a scale of 0-10. 0 is the minimum and 10 is maximum on this scale. Lower scores mean a better outcome.

Time frame: 20 minutes

Population: adults with nasal congestion

ArmMeasureValue (MEAN)
TreatmentVisual Analog Scale (VAS) for Headache0.9 score on a scale of 0-10

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026